慢性的な鉄の投与は,血管の酸化ストレスを増加させ,動脈血栓形成を加速させます
Sharlene M Day1, Damon Duquaine, Lakshmi V Mundada
1University of Michigan Medical School, Division of Cardiology, Ann Arbor, USA. sday@umich.edu
Circulation
|May 7, 2003
まとめ
過剰な鉄は,動脈損傷後の血栓形成を加速し,酸化ストレスを増加させ,血管機能を損なう. この鉄による血管機能障害は,不全性心血管疾患のリスクを増やす可能性があります.
科学分野:
- 心血管研究 循環器科の研究
- 血液学 ヘマトロジ
- 酸化ストレス生物学 生物学
背景:
- 鉄過負荷は,心血管不全症のイベントと関連しています.
- 過剰な鉄が血管機能と血栓形成に与える影響は不明である.
研究 の 目的:
- 慢性的な鉄の負荷が血栓形成,酸化ストレス,およびマウスの血管反応性に対する影響を調査する.
- 鉄の過剰が血管の健康と血栓反応に影響を与えるメカニズムを解明する.
主な方法:
- マウスは6週間にわたって慢性的な鉄デクストラン投与を受けた.
- 血栓症は,光化学的頸動脈損傷後に評価されました.
- 系統的および血管の酸化ストレス,および内皮に依存する血管活性が測定されました.
主要な成果:
- 鉄分を摂取したマウスは,血栓形成の加速を示した (20.4分対54.5分).
- 鉄の負荷は,全身および血管の反応性酸素種生産を増加させた.
- 内皮に依存する血管リラックスが損なわれ,酸化窒素の生物利用性が低下したことを示した.
結論:
- 適度な鉄の負荷は,血栓形成を加速し,血管の酸化ストレスを増加させます.
- 鉄が誘発した血管機能障害は,不全性心血管疾患に寄与する.
- 鉄過負荷は,心血管合併症の危険因子である.
関連する概念動画
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...


